Go to deals
Private Equity | Healthcare

Reed Veterinary Surgery has been acquired by Kin Vet Community

The acquisition of Reed Veterinary Surgery by Kin Vet Community has been successfully completed. Through this acquisition, the surgery joins a community of veterinary clinics where colleagues share knowledge and best practices to improve the wellbeing of their clients and their animals.

Reed Veterinary Surgery is a high quality and well-regarded first opinion small animal veterinary practice. It operates from a single facility near Royston, Hertfordshire, UK. The surgery has a team of around 15 employees.

Launched in 2023, Kin Vet Community is a group of UK-based veterinary clinics, predominately across the east of England. The company is headquartered in Bury St. Edmunds, Suffolk, UK.

Oaklins S&W, one of Oaklins’ member firms in the UK, acted as lead advisor to the proprietors on the sale of the trade and assets of the business to Kin Vet. The team advised on all aspects of the transaction, from initial buyer research and preparation for sale to the preparation of marketing documents, leading negotiations and buyer meetings, managing due diligence and general project management throughout the deal.

Parties
“We are incredibly thankful for all that Oaklins S&W has done to get this deal over the line. It has been a process not without its challenges, but they have been unwavering in their commitment to get the best result for us and have provided first-rate guidance and reassurance from start to finish. We know this deal wouldn’t have been secured without their advice, and we highly recommend the team to anyone who is considering selling their business.”

Proprietors

Reed Veterinary Surgery

Talk to the deal team

Tom Gallop

Partner
Cambridge, United Kingdom
Oaklins S&W

Chris Pell

Manager
Cambridge, United Kingdom
Oaklins S&W

Related deals

Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more
IXICO has completed a fundraising
Healthcare

IXICO has completed a fundraising

IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.

Learn more